Relationships between blood rheology and age, body mass index, blood cell count, fibrinogen, and lipids in healthy subjects.

We investigated the relationships between blood rheology assessed by microchannel method and the various hemorheologic factors in healthy subjects. One hundred seventy-six healthy volunteers (90 men and 86 women, mean age; 32.9+/-11.3 years) were participated in this study. Body weight, body mass index, red blood cell count, hematocrit, hemoglobin, white blood cell count, and platelet count, plasma fibrinogen, and fasting serum lipid and lipoprotein concentrations were measured. In order to assess blood rheology, blood passage time was determined by a microchannel method (Micro Channel Array Flow Analyzer). Age, body mass index, red blood cell count, hematocrit, hemoglobin, white blood cell count, total cholesterol, low-density lipoprotein cholesterol, and triglyceride were positively correlated with blood passage time in all subjects, respectively (p<0.01) and high-density lipoprotein cholesterol was inversely correlated with blood passage time (p<0.01). However, platelet count, and fibrinogen were not correlated with blood passage time. The present study showed that increased age, body mass index, red blood cell count, white blood cell count, total cholesterol, low-density lipoprotein cholesterol, and triglyceride and decreased high-density lipoprotein cholesterol were associated with impaired blood rheology measured by microchannel method in healthy subjects, suggesting that aging, obesity, erythrocytosis, leukocytosis, and dyslipidemia may be related to hemorheological disorders. This microchannel method may be useful to study blood rheology which may be associated with various risk factors of cardiovascular disorders.

[1]  M. Kurabayashi,et al.  Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women. , 2006, Maturitas.

[2]  T Takahashi,et al.  Effect of Antihypertensive Therapy on Blood Rheology in Patients with Essential Hypertension , 2005, Journal of International Medical Research.

[3]  I. Shapira,et al.  Flow-resistant red blood cell aggregation in morbid obesity , 2004, International Journal of Obesity.

[4]  Cherl‐Ho Lee,et al.  Rheological properties of erythrocytes from male hypercholesterolemia. , 2004, Microvascular research.

[5]  S. Shott,et al.  Hypertriglyceridemia and other factors associated with plasma viscosity. , 2001, The American journal of medicine.

[6]  M. Woodward,et al.  Associations of blood rheology and interleukin‐6 with cardiovascular risk factors and prevalent cardiovascular disease , 1999, British journal of haematology.

[7]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[8]  A. Döring,et al.  Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[9]  P L Allan,et al.  Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. , 1998, Circulation.

[10]  R. Rosenson,et al.  Treatment of severe hypertriglyceridemia lowers plasma viscosity. , 1998, Atherosclerosis.

[11]  A. Rumley,et al.  Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study , 1997, British journal of haematology.

[12]  Y Kikuchi,et al.  Effect of leukocytes and platelets on blood flow through a parallel array of microchannels: micro- and macroflow relation and rheological measures of leukocyte and platelet activities. , 1995, Microvascular research.

[13]  R. Epand,et al.  HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[14]  A. G. Shaper,et al.  Ischaemic heart disease: association with haematocrit in the British Regional Heart Study. , 1994, Journal of epidemiology and community health.

[15]  W. Kannel,et al.  Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up. , 1994, American heart journal.

[16]  E. Ernst,et al.  Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.

[17]  H. Ohki,et al.  Optically accessible microchannels formed in a single-crystal silicon substrate for studies of blood rheology. , 1992, Microvascular research.

[18]  W. Koenig,et al.  Lovastatin Alters Blood Rheology in Primary Hyperlipoproteinemia: Dependence on Lipoprotein(a)? , 1992, Journal of clinical pharmacology.

[19]  W. Koenig,et al.  The possible role of hemorheology in atherothrombogenesis. , 1992, Atherosclerosis.

[20]  W. Koenig,et al.  Association Between Rheology and Components of Lipoproteins in Human Blood: Results From the MONICA Project , 1992, Circulation.

[21]  W. Koenig,et al.  Association between plasma viscosity and blood pressure. Results from the MONICA-project Augsburg. , 1991, American journal of hypertension.

[22]  C. Forbes,et al.  Relationships of Plasma Viscosity, Coagulation and Fibrinolysis to Coronary Risk Factors and Angina , 1991, Thrombosis and Haemostasis.

[23]  P C Elwood,et al.  Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.

[24]  J. Dormandy,et al.  Leukocytes and the risk of ischemic diseases. , 1987, JAMA.

[25]  L. Kuller,et al.  SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN , 1986, The Lancet.

[26]  H. Weiss,et al.  PLATELET AND RED CELL INVOLVEMENT IN MURAL THROMBOGENESIS a , 1983, Annals of the New York Academy of Sciences.

[27]  H. Arntz,et al.  Studies of plasma viscosity in primary hyperlipoproteinaemia. , 1977, Atherosclerosis.

[28]  J. Dormandy,et al.  A simple method for measuring erythrocyte deformability. , 1976, Journal of clinical pathology.

[29]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[30]  D. Corella,et al.  Influence of plasmatic lipids on the hemorheological profile in healthy adults. , 2004, Clinical hemorheology and microcirculation.

[31]  E. Mironova,et al.  Plasma lipid levels, blood rheology, platelet aggregation, microcirculation state and oxygen transfer to tissues in young and middle-aged healthy people. , 2004, Clinical hemorheology and microcirculation.

[32]  I. Cicha,et al.  Effects of dietary triglycerides on rheological properties of human red blood cells (abstract). , 2004, Clinical hemorheology and microcirculation.

[33]  T. Kurihara,et al.  Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver disease. , 2001, Clinical hemorheology and microcirculation.

[34]  K. Sato,et al.  Modified cell-flow microchannels in a single-crystal silicon substrate and flow behavior of blood cells. , 1994, Microvascular research.

[35]  H. Tunstall-Pedoe,et al.  Epidemiology of haematocrit, white cell count, red cell aggregation and fibrinogen: The Glasgow MONICA study , 1992 .

[36]  S Chien,et al.  Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. , 1990, Circulation.

[37]  F. R. Smith,et al.  Effects of lipoproteins on plasma viscosity. , 1981, Atherosclerosis.

[38]  W. Kannel,et al.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.